Simulations Plus Delivers Strong Q2 Results
Simulations Plus (SLP) tops Q2 earnings and revenue estimates, driven by strong demand for its software and services in the pharmaceutical and biotech industries. The company's growth momentum continues, with a 22% increase in revenue and a 34% rise in earnings per share.